Bandi Linea B

MuScMeC-BP

Multiscale Mechanical Characterization of Bovine Pericardium
Eco healthcare
Scheda del progetto
Data
Start date
Valore
Total value
€ 49.975,00
Durata
Duration
12 months
Investimento
Investment nodes
€ 24.987,00

MuScMeC-BP is a consultancy service provided by the PAsTISs research infrastructure, aimed at understanding and improving the performance of biological materials, as well as identifying the fundamental mechanical properties needed to characterize them for the design of engineered substitutes. This service would allow Epygon Italie to acquire essential information on the mechanical behavior of the materials used in the fabrication of their products, based on decellularized bovine pericardium sheets (FPBD), raw material used by the company for the production of valve leaflets employed in the fabrication of their mitral valve prosthesis. 

 

 

Contact:

Mark Pace Floridia 

mark.pace-floridia@affluentmedical.com

The goal
Document

The company seeks to improve the EPYGON prosthesis in order to promote biomedical research and improve patient health by reducing waste and pollution. The service aims to strengthen research and technology transfer to develop innovative and sustainable therapeutic strategies for vulnerable patients. 

Why is it innovative
Document

The service requested by the company aims to integrate visual data with mechanical parameters to evaluate bovine pericardium leaflets at both micro and macroscales. going beyond the current mechanical characterization. A digital archive will be created to optimise material selection and production processes. The expected outcomes include improved quality control, identification of new raw materials, increased company knowledge and product/process development.  

Impact on the users
Document

The service will have a significant impact on different company departments: production will see improvements in control protocols and valve prosthesis manufacturing, reducing waste and the use of pollutants; the R&D department will benefit from increased know-how and design capability, reducing development costs; bovine pericardium suppliers will receive more precise guidance on material requirements; regulatory agencies will receive detailed quantitative parameters on the material used.